News
2h
Zacks Investment Research on MSNWall Street Analysts See a 161.51% Upside in uniQure (QURE): Can the Stock Really Move This High?Qure (QURE) closed the last trading session at $12.81, gaining 32.8% over the past four weeks, but there could be plenty of ...
2h
Zacks Investment Research on MSNWall Street Analysts See a 195.05% Upside in Trevi Therapeutics (TRVI): Can the Stock Really Move This High?Shares of Trevi Therapeutics, Inc. (TRVI) have gained 4.1% over the past four weeks to close the last trading session at ...
US stocks dropped as Wall Street braced for a busy day of Big Tech earnings and digested President Trump's latest move on tariffs.
It’s a big shift from less than two weeks ago, when Trump reposted a video claiming he was “crashing the stock market…on ...
TradingView's powerful charting tools are unmatched in the industry, providing deep insights into stock movements. Ziggma offers a comprehensive stock screener that combines fundamental and ...
Target shoppers in New Jersey and across the U.S. have stopped spending money at Target. Here's why, what to know about ...
After a two-year surge of 53%, the stock market has been taken for a wild ride in 2025, driven by uncertainties surrounding ...
1st Source (SRCE) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of ...
AdaptHealth Corp. (AHCO) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results